Following completion of the Congress, participants will be better able to:
Apply new scientific data and clinical guidelines to improve patient selection and treatment outcomes for neuromodulation.
Identify potential benefits, limitations and complications of neuromodulation therapies.
Interpret study results based on trial design and apply lessons learned for application in the design of future trials.
Analyze and understand psychological/psychiatric factors affecting outcomes in the treatment of chronic pain, movement disorders, cognitive and other disorders.
Describe the bioengineering challenges and solutions at the neural interface, fundamentals and mechanisms of action of neuromodulation.
Discuss and analyze the anatomy and physiology of the central CNS, peripheral and autonomic nervous systems to assist in patient selection, target selection and likelihood of therapeutic success.
Discuss the uses of devices for functional electrical stimulation including rehabilitation of motor loss, loss of sensory function, and loss of cognitive function.
Describe emerging neuromodulation therapies, new paradigms of therapy target selection and associated research in the medical field of neuromodulation.
Distinguish mechanisms of disease states, cardiovascular disease and visceral pain syndromes and explain the current position of neuromodulation in these conditions.
Explain the many variations now available in neuromodulation and how to select the appropriate technology.
Explain the scientific merit and best practices for the use of intrathecal drug infusions including patient selection, drug selection and complication management.
Critically appraise research methodology in neuromodulation and recognize how evolving treatment guidelines and registries are important.
Apply the increasing knowledge base for neuromodulation in a wide variety of chronic illness management.
Explain how cancer pain management has evolved into managing the pain of cancer survivors and recognize the growing need for neuromodulation solutions.